Nihon Kohden Corporation (OTCMKTS:NHNKY) Sees Significant Decrease in Short Interest

Nihon Kohden Corporation (OTCMKTS:NHNKY) was the target of a large decline in short interest during the month of August. As of August 14th, there was short interest totaling 2,205 shares, a decline of 61.7% from the July 30th total of 5,764 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 18,091 shares, the days-to-cover ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

Separately, UBS Group cut shares of Nihon Kohden from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 12th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has an average rating of “Hold”.

Nihon Kohden Stock Performance

Shares of OTCMKTS:NHNKY opened at $9.26 on Friday. The business’s fifty day moving average price is $9.33 and its two-hundred day moving average price is $9.53. The stock has a market cap of $1.56 billion, a PE ratio of 16.84 and a beta of 0.37. Nihon Kohden has a one year low of $8.12 and a one year high of $14.21.

Nihon Kohden (OTCMKTS:NHNKY) last issued its quarterly earnings data on Thursday, August 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.09). The company had revenue of $297.47 million during the quarter, compared to analysts’ expectations of $299.98 million. Nihon Kohden had a net margin of 5.90% and a return on equity of 9.08%. As a group, equities research analysts predict that Nihon Kohden will post 0.6 earnings per share for the current fiscal year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.